Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
home:publications:marshall_theoretical_2006 [03.08.2019] – [Conclusion] sallieqhome:publications:marshall_theoretical_2006 [07.04.2022] (current) – external edit 127.0.0.1
Line 11: Line 11:
 **Citation:**  Marshall, T.G., Lee, R.E. & Marshall, F.E. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. //Theoretical biology & medical modelling// 3, 1(2006). **Citation:**  Marshall, T.G., Lee, R.E. & Marshall, F.E. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. //Theoretical biology & medical modelling// 3, 1(2006).
 \\ \\
-**See also:** [[http://www.tbiomed.com/content/3/1/1|full text]]; [[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1360063|PubMed Central record]]+**See also:** [[https://www.tbiomed.com/content/3/1/1|full text]]; [[https://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1360063|PubMed Central record]] 
 + 
 +//And see// **Editor's note** //below//
  
  
Line 33: Line 35:
 ==== Editor's note ==== ==== Editor's note ====
  
-Professor Marshall now says+(//since 2008//)  Professor Marshall now says
 <blockquote>I am certain that the primary mode of action of Olmesartan is agonism of the human VDR, and the subsequent reconditioning of the human immune system. <blockquote>I am certain that the primary mode of action of Olmesartan is agonism of the human VDR, and the subsequent reconditioning of the human immune system.
  
home/publications/marshall_theoretical_2006.txt · Last modified: 07.04.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.